Mesenchymal chondrosarcoma : Clinicopathologic study of 20 cases

Archives of Pathology and Laboratory Medicine

Volumn 136, Issue 1, 2012, Pages 61-75

  Shakked, Rachel J ^a   Geller, David S ^a   Gorlick, Richard ^b   Dorfman, Howard D ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOX9 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX9; TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; ARTICLE; BONE; BONE TUMOR; CASE REPORT; CHILD; CHONDROSARCOMA; FEMALE; FOLLOW UP; HUMAN; MALE; METABOLISM; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; RADIOGRAPHY; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADOLESCENT; ADULT; BONE AND BONES; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; CHONDROSARCOMA, MESENCHYMAL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SOX9 TRANSCRIPTION FACTOR; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84856036712     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2010-0362-OA     Document Type: Article

References (49)

1. Lichtenstein L, Bernstein D. Unusual benign and malignant chondroid tumors of bone: a survey of some mesenchymal cartilage tumors and malignant chondroblastic tumors, including a few multicentric ones, as well as many atypical benign chondroblastomas and chondromyxoid fibromas. Cancer. 1959; 12(6):1142-1157.
2. Huvos AG, Rosen G, Dabska M, Marcove RC. Mesenchymal chondrosarcoma: a clinicopathologic analysis of 35 patients with emphasis on treatment. Cancer. 1983;51(7):1230-1237. (Pubitemid 13161100)
3. Nakashima Y, Unni KK, Shives TC, Swee RG, Dahlin DC. Mesenchymal chondrosarcoma of bone and soft tissue: a review of 111 cases. Cancer. 1986; 57(12):2444-2453. (Pubitemid 16118989)
4. Salvador AH, Beabout JW, Dahlin DC. Mesenchymal chondrosarcoma- observations on 30 new cases. Cancer. 1971;28(3):605-615.
5. Bertoni F, Picci P, Bacchini P, et al. Mesenchymal chondrosarcoma of bone and soft tissues. Cancer. 1983;52(3):533-541. (Pubitemid 13073483)
6. Nakashima Y, Park YK, Sugano O. Mesenchymal chondrosarcoma. In: Fletcher CDM, Unni KK, Mertens F, eds. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:255-256. World Health Organization Classification of Tumours; vol 4.
7. Dorfman HD, Czerniak B. Bone cancers. Cancer. 1995;75(suppl 1):203-210.
8. Horner MJ, Ries LAG, Krapcho M, et al, eds. SEER cancer statistics review: tumors of adolescents and young adults, table 32.1; 2002-2006. 2009 ed. Bethesda, Maryland: National Cancer Institute. http://seer.cancer.gov/csr/1975- 2006. Accessed March 3, 2010.
9. Chen JY, Hsu SS, Ho JT. Extraskeletal intracranial mesenchymal chondrosarcoma: case report and literature review. Kaohsiung J Med Sci. 2004;20(5):240-246.
10. Crosswell H, Buchino JJ, Sweetman R, Reisner A. Intracranial mesenchymal chondrosarcoma in an infant. Med Pediatr Oncol. 2000;34(5):370-374.
11. De Padua M, Bhandari TP. Primary mesenchymal chondrosarcoma of the breast. Indian J Pathol Microbiol. 2009;52(1):129-130.
12. Font RL, Ray R, Mazow ML, Del Valle M. Mesenchymal chondrosarcoma of the orbit: a unique radiologic-pathologic correlation. Ophthal Plast Reconstr Surg. 2009;25(3):219-222.
13. Gatter KM, Olson S, Lawce H, Rader AE. Trisomy 8 as the sole cytogenetic abnormality in a case of extraskeletal mesenchymal chondrosarcoma. Cancer Genet Cytogenet. 2005;159(2):151-154. (Pubitemid 40719385)
14. Gomez-Brouchet A, Soulie M, Delisle MB, Escourrou G. Mesenchymal chondrosarcoma of the kidney. J Urol. 2001;166(6):2305. (Pubitemid 33065284)
15. Huang KF, Tzaan WC, Lin CY. Primary intraspinal mesenchymal chondrosarcoma: a case report and literature review. Chang Gung Med J. 2003;26(5):370-376.
16. Luppi G, Cesinaro AM, Zoboli A, Morandi U, Piccinini L. Mesenchymal chondrosarcoma of the pleura. Eur Respir J. 1996;9(4):840-843. (Pubitemid 26167893)
17. Odashiro AN, Leite LV, Oliveira RS, et al. Primary orbital mesenchymal chondrosarcoma: a case report and literature review. Int Ophthalmol. 2009; 29(3):173-177.
18. Sugiyama K, Hirano A, Llena JF, et al. Mesenchymal chondrosarcoma in anterior skull base: case report. Noshuyo Byori. 1996;13(1):57-60.
19. Tuncer S, Kebudi R, Peksayar G, et al. Congenital mesenchymal chondrosarcoma of the orbit: case report and review of the literature. Ophthalmology. 2004;111(5):1016-1022. (Pubitemid 38586699)
20. Zakkak TB, Flynn TR, Boguslaw B, Adamo AK. Mesenchymal chondrosarcoma of the mandible: case report and review of the literature. J Oral Maxillofac Surg. 1998;56(1):84-91. (Pubitemid 28052980)
21. Cesari M, Bertoni F, Bacchini P, Mercuri M, Palmerini E, Ferrari S. Mesenchymal chondrosarcoma: an analysis of patients treated at a single institution. Tumori. 2007;93(5):423-427. (Pubitemid 350203913)
22. Dabska M, Huvos AG. Mesenchymal chondrosarcoma in the young. Virchows Arch A Pathol Anat Histopathol. 1983;399(1):89-104.
23. Dantonello TM, Int-Veen C, Leuschner I, et al. Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups. Cancer. 2008;112(11):2424-2431.
24. Knott PD, Gannon FH, Thompson LD. Mesenchymal chondrosarcoma of the sinonasal tract: a clinicopathological study of 13 cases with a review of the literature. Laryngoscope. 2003;113(5):783-790. (Pubitemid 36539148)
25. Vencio EF, Reeve CM, Unni KK, Nascimento AG. Mesenchymal chondrosarcoma of the jaw bones: clinicopathologic study of 19 cases. Cancer. 1998;82(12):2350-2355. (Pubitemid 28283441)
26. Hashimoto N, Ueda T, Joyama S, et al. Extraskeletal mesenchymal chondrosarcoma: an imaging review of ten new patients. Skeletal Radiol. 2005; 34(12):785-792. (Pubitemid 41754619)
27. Dorfman HD, Czerniak B. Bone Tumors. St. Louis, MO: CV Mosby Co; 1998:421-435.
28. Granter SR, Renshaw AA, Fletcher CD, Bhan AK, Rosenberg AE. CD99 reactivity in mesenchymal chondrosarcoma. Hum Pathol. 1996;27(12):1273-1276. (Pubitemid 26415318)
29. Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer. 1991;67(7):1886-1893.
30. Wehrli BM, Huang W, De Crombrugghe B, Ayala AG, Czerniak B. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. Hum Pathol. 2003;34(3):263-269. (Pubitemid 36356679)
31. Fanburg-Smith JC, Auerbach A, Marwaha JS, Wang Z, Rushing EJ. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and b-catenin, Sox9, and osteocalcin immunostaining of 22 cases. Hum Pathol. 2010;41(5):653-662.
32. Muller S, Soder S, Oliveira AM, Inwards CY, Aigner T. Type II collagen as specific marker for mesenchymal chondrosarcomas compared to other small cell sarcomas of the skeleton. Mod Pathol. 2005;18(8):1088-1094. (Pubitemid 41224499)
33. Lee AF, Hayes MM, LeBrun D, et al. FLI-1 distinguishes Ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma. Appl Immunohistochem Mol Morphol. 2011;19(3):233-238.
34. Sakamoto A, Oda Y, Iwamoto Y, TsuneyoshiM. Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis onmesenchymal and dedifferentiated chondrosarcoma. J Cancer Res Clin Oncol. 1999;125(10):541-548. (Pubitemid 29434878)
35. Dobin SM, Donner LR, Speights VO Jr. Mesenchymal chondrosarcoma: a cytogenetic, immunohistochemical and ultrastructural study. Cancer Genet Cytogenet. 1995;83(1):56-60.
36. Mandahl N, Heim S, Arheden K, Rydholm A, Willen H, Mitelman F. Chromosomal rearrangements in chondromatous tumors. Cancer. 1990;65(2):242-248.
37. Naumann S, Krallman PA, Unni KK, Fidler ME, Neff JR, Bridge JA. Translocation der(13;21)(q10;q10) in skeletal and extraskeletal mesenchymal chondrosarcoma. Mod Pathol. 2002;15(5):572-576. (Pubitemid 34521407)
38. Richkind KE, Romansky SG, Finklestein JZ. t(4;19)(q35;q13.1): a recurrent change in primitivemesenchymal tumors? Cancer Genet Cytogenet. 1996;87(1):71-74.
39. Rushing EJ, Armonda RA, Ansari Q, Mena H. Mesenchymal chondrosarcoma: a clinicopathologic and flow cytometric study of 13 cases presenting in the central nervous system. Cancer. 1996;77(9):1884-1891. (Pubitemid 26125191)
40. Sainati L, Scapinello A, Montaldi A, et al. A mesenchymal chondrosarcoma of a child with the reciprocal translocation (11;22)(q24;q12). Cancer Genet Cytogenet. 1993;71(2):144-147. (Pubitemid 24040014)
41. Szymanska J, Tarkkanen M, Wiklund T, et al. Cytogenetic study of extraskeletal mesenchymal chondrosarcoma: a case report. Cancer Genet Cytogenet. 1996;86(2):170-173. (Pubitemid 26074813)
42. Roberts P, Burchill SA, Brownhill S, et al. Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing's sarcoma family of tumors: a study by the United Kingdom Cancer Cytogenetics and the Children's Cancer and Leukaemia Group. Genes Chromosomes Cancer. 2008;47(3):207-220. (Pubitemid 351162852)
43. Turc-Carel C, Aurias A, Mugneret F, et al. Chromosomes in Ewing's sarcoma, I: an evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet Cytogenet. 1988;32(2):229-238.
44. Nussbeck W, Neureiter D, Soder S, Inwards C, Aigner T. Mesenchymal chondrosarcoma: an immunohistochemical study of 10 cases examining prognostic significance of proliferative activity and cellular differentiation. Pathology. 2004;36(3):230-233. (Pubitemid 38748082)
45. Park YK, Park HR, Chi SG, et al. Overexpression of p53 and rare genetic mutation in mesenchymal chondrosarcoma. Oncol Rep. 2000;7(5):1041-1047.
46. Brown RE, Boyle JL. Mesenchymal chondrosarcoma: molecular characterization by a proteomic approach, with morphogenic and therapeutic implications. Ann Clin Lab Sci. 2003;33(2):131-141. (Pubitemid 36705922)
47. Croce CM. Oncogenes and cancer. N Engl J Med. 2008;358(5):502-511. (Pubitemid 351185806)
48. Gorelik B, Ziv I, Shohat R, et al. Efficacy of weekly docetaxel and bevacizumab in mesenchymal chondrosarcoma: a new theranostic method combining xenografted biopsies with a mathematical model. Cancer Res. 2008; 68(21):9033-9040.
49. Fujisawa N, Sato NL, Motoyama TI. Inhibitory effects of transforming growth factor-b1 pretreatment on experimental pulmonary metastasis of MCS-1 Chinese hamster mesenchymal chondrosarcoma cells. Tohoku J Exp Med. 1999; 187(3):203-213.